Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of method for preparing linaclotide

A linaclotide, a pair of technology, applied in the field of preparation of linaclotide, can solve the problems of complex processing process, less source of raw materials, high cost, etc., achieve simple process operation, and avoid disulfide bond mismatch isomer impurities , the effect of reducing the difficulty of purification

Inactive Publication Date: 2018-09-14
JINAN KANGHE MEDICAL TECH
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the one-step oxidation method can convert the linear peptide to the target structure as much as possible through the buffer system, it still cannot avoid the generation of disulfide bond mismatch isomer impurities, and the yield is low
[0007] Patent CN103626849A discloses the use of the same solution system to form three pairs of disulfide bonds step by step. Although this method can avoid the production of disulfide bond mismatch isomer impurities, the same system reacts, the processing process is complicated, and the source of raw materials is less , the cost is relatively high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of method for preparing linaclotide
  • A kind of method for preparing linaclotide
  • A kind of method for preparing linaclotide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1: Preparation of Fmoc-Cys(Mmt)-CTC resin

[0043] Accurately weigh 320 g of CTC resin (1.0 mmol / g) into a peptide resin synthesis reactor, and add 3 L of DCM to swell for 1 h. After the swelling was completed, the cells were washed three times with DMF, each 3L. Weigh 394 g of Fmoc-Cys(Mmt)-OH and 87 g of HOBt to dissolve in 2L DMF, add 110mL DIC to activate, add the solution to the reactor, and react for 4h. After the reaction was completed, the resin was washed three times with DMF, and then a pre-prepared capping reagent (2.5L DCM, 0.3L methanol, 0.2L DIEA) was added, and the end capping reaction was carried out for 1 h. After the end capping was completed, DMF was washed 4 times, DCM was washed twice, and methanol was washed 3 times, 3 L each time, and then the resin was vacuum-dried to obtain 507 g of Fmoc-Cys(Mmt)-CTC resin. Take a small amount of resin and measure Fmoc-Cys The substitution degree of (Mmt)-CTC resin was 0.61 mmol / g. The synthesis scale...

Embodiment 2

[0044] Example 2: Preparation of Fragment I Peptide Resin

[0045] 493 g (300 mmol) of Fmoc-Cys(Mmt)-CTC resin with a substitution degree of 0.61 mmol / g in Example 1 was weighed and placed in a peptide resin synthesis reactor, and 4 L of DCM was added to swell for 2 h. After the swelling was completed, washed with DMF for 3 times, each 4L, and then added 4L of 20% piperidine / DMF solution for deprotection twice for 10min and 10min respectively. After deprotection, the resin was washed 6 times with DMF, 4 L each time. Weigh Fmoc-Cys(Trt)-OH 352g and HOBt 81g to dissolve in 2L DMF, add 103mL DIC to activate, add the solution to the reactor, react for 2h, and monitor the reaction end point with Kaiser test. After the reaction was completed, the resin was washed 5 times with DMF, and then the next protected amino acid was deprotected and coupled. Repeat the above steps, and sequentially carry out the coupling of Fmoc-Tyr(tBu)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Cys(Acm)-OH, Fmoc-Cys(Mmt)...

Embodiment 3

[0046] Example 3: Preparation of Fragment I Linear Peptides

[0047] Weigh 700 g (200 mmol) of fragment I peptide resin obtained in Example 2 into a 10 L reaction flask, add 7 L of cleavage reagent TFA-TIS-DCM (5-5-90), and react at room temperature for 5 min. At the end of the reaction, the lysate was filtered into a suction filter bottle. The above-mentioned cleavage reaction was repeated 3 times, and the filtrate was combined with the same volume of 0.1mol / L NaHCO. 3 The filtrate was washed with an aqueous solution until the pH of the solution was 7-8, concentrated by rotary evaporation at 25 °C, the precipitated precipitate was collected by filtration, and vacuum-dried to obtain 261 g of fragment I linear peptide with a purity of 82.3% and a yield of 95%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
purityaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of polypeptide synthesis, in particular to a method for preparing linaclotide. In this experiment, the fragment method was used to synthesize the linaclotide peptide chain, and three pairs of disulfide bonds were formed in three steps with complete selectivity. The specific steps were: a) synthesis of fragment I linear peptide; b) formation of the first pair of disulfide bonds bond to obtain fragment I oxidized peptide; c) synthesis of fragment II peptide resin; d) synthesis of linaclotide crude peptide containing a pair of disulfide bonds; e) synthesis of the second pair of disulfide bonds; f) synthesis of the third pair of disulfide bonds sulfur bond. This method adopts the method of forming three pairs of disulfide bonds in three steps with complete selectivity to prepare linaclotide, which can avoid isomer impurities with mismatched disulfide bonds and reduce the difficulty of the purification process. The difficulty of forming a pair of disulfide bonds makes the purity and yield of the final crude peptide higher, the operation process is simple, and it is suitable for large-scale production.

Description

technical field [0001] The present invention relates to the field of polypeptide synthesis, in particular to a method for preparing linaclotide. technical background [0002] Linaclotide (LINZESS) is a polypeptide drug developed by Ironwood Pharmaceuticals in the United States and was first approved in the United States on December 17, 2012 for the treatment of gastrointestinal diseases. , Finland, Germany, Norway, Sweden, the United Kingdom and other countries listed on the market, but has not yet declared for import into China (but an international multi-center clinical phase III trial has been conducted in China). This product is the only FDA-approved GC-C (guanylate cyclase-C) agonist drug that can be used for clinical use locally, and it is also the first approved in Europe for the treatment of adults with moderate to severe IBS-C Novel prescription drugs for patients. The specifications of LINACLOTIDE capsules are: 145MCG / capsule; 290MCG / capsule. [0003] Linaclotid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/08C07K1/08C07K1/06C07K1/04
CPCY02P20/55
Inventor 张颖王德龙王仁友李同金石鑫磊
Owner JINAN KANGHE MEDICAL TECH